ADAPTIMMUNE THERAPEUTICS PLC Debt Securities, Available-for-sale, Amortized Cost
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Debt Securities, Available-for-sale, Amortized Cost of $9.19 million as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Notes › Credit Loss, Additional Improvements
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2025-05-13
- 2025-03-31: Debt Securities, Available-for-sale, Amortized Cost $9.19M.
- 2024-09-30: Debt Securities, Available-for-sale, Amortized Cost $4.00M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2025-03-31 | $9.19M 10-Q · filed 2025-05-13 |
| 2024-09-30 | $4.00M 10-Q · filed 2024-11-13 |